Caissie Amanda, Mierzwa Michelle, Fuller Clifton David, Rajaraman Murali, Lin Alex, MacDonald Andrew, Popple Richard, Xiao Ying, VanDijk Lisanne, Balter Peter, Fong Helen, Xu Heping, Kovoor Matthew, Lee Joonsang, Rao Arvind, Martel Mary, Thompson Reid, Merz Brandon, Yao John, Mayo Charles
Dalhousie University, Halifax, Nova Scotia, Canada.
University of Michigan, Ann Arbor, Michigan.
Adv Radiat Oncol. 2022 Feb 23;8(1):100925. doi: 10.1016/j.adro.2022.100925. eCollection 2023 Jan-Feb.
Outside of randomized clinical trials, it is difficult to develop clinically relevant evidence-based recommendations for radiation therapy (RT) practice guidelines owing to lack of comprehensive real-world data. To address this knowledge gap, we formed the Learning from Analysis of Multicenter Big Data Aggregation consortium to cooperatively implement RT data standardization, develop software solutions for data analysis, and recommend clinical practice change based on real-world data analyzed. The first phase of this "Big Data" study aimed at characterizing variability in clinical practice patterns of dosimetric data for organs at risk (OARs) that would undermine subsequent use of large-scale, electronically aggregated data to characterize associations with outcomes. Evidence from this study was used as the basis for practical recommendations to improve data quality.
Dosimetric details of patients with head and neck cancer treated with radiation therapy between 2014 and 2019 were analyzed. Institutional patterns of practice were characterized, including structure nomenclature, volumes, and frequency of contouring. Dose volume histogram (DVH) distributions were characterized and compared with institutional constraints and literature values.
Plans for 4664 patients treated to a mean plan dose of 64.4 ± 13.2 Gy in 32 ± 4 fractions were aggregated. Before implementation of TG-263 guidelines in each institution, there was variability in OAR nomenclature across institutions and structures. With evidence from this study, we identified a targeted and practical set of recommendations aimed at improving the quality of real-world data.
Quantifying similarities and differences among institutions for OAR structures and DVH metrics is the launching point for next steps to investigate potential relationships between DVH parameters and patient outcomes.
在随机临床试验之外,由于缺乏全面的真实世界数据,很难为放射治疗(RT)实践指南制定具有临床相关性的循证建议。为了填补这一知识空白,我们组建了多中心大数据聚合分析学习联盟,以合作实施放疗数据标准化,开发数据分析软件解决方案,并根据分析的真实世界数据推荐临床实践变革。这项“大数据”研究的第一阶段旨在描述危及器官(OARs)剂量学数据临床实践模式的变异性,这种变异性会影响后续使用大规模电子聚合数据来描述与预后的关联。本研究的证据被用作改进数据质量的实用建议的基础。
分析了2014年至2019年间接受放射治疗的头颈癌患者的剂量学细节。对机构的实践模式进行了描述,包括结构命名、体积和轮廓勾画频率。对剂量体积直方图(DVH)分布进行了描述,并与机构限制和文献值进行了比较。
汇总了4664例患者的计划,平均计划剂量为64.4±13.2 Gy,分32±4次给予。在各机构实施TG-263指南之前,各机构和结构之间的OAR命名存在差异。基于本研究的证据,我们确定了一套有针对性且实用的建议,旨在提高真实世界数据的质量。
量化各机构在OAR结构和DVH指标方面的异同,是下一步研究DVH参数与患者预后潜在关系的出发点。